Curis anticipates TakeAim CLL initial 5-patient dosing by mid-2026 while projecting cash runway into second half of '27

S&P 500 Ends Flat, While Nasdaq Drops As Memory Chipmakers Sell Off — BAC, GME, SPCX, ARM, QCOM In Focus

10/13/2026

What Just Happened To Joby Stock?

10/13/2026

Can Phinia Stock Compound Your Money?

10/13/2026

Enovix surges on 100K-unit drone battery order

10/13/2026